Latest filing published 21 Feb 2023 for Codiak BioSciences, Inc..
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +64.0%Entry US$2.03 · Close at T+365 US$3.33
- -69.1%Entry US$6.87 · Close at T+365 US$2.12
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Karen Bernstein: trading record in brief
Karen Bernstein is a declared insider at 2 companies; the most frequent names are Ovid Therapeutics Inc. and Codiak BioSciences, Inc. Over a trading history stretching from 14 August 2018 to 16 February 2023, the count stands at 3 filings.
Purchases make up the whole of the open-market record (2 purchases, €73k). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 1 option exercise.
The newest entry dates from 21 February 2023: an option exercise, in Codiak BioSciences, Inc. The last insider purchase was made public on 28 February 2019, 2,811 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Karen Bernstein
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 8,750 sharesCommon StockSEC:0000899243-23-005693:0
- 10,000 shares@ US$2.0224.4% of flowCommon StockSEC:0001209191-19-014804:0Canonical exit: 27 May 2019 (T+90)
- 10,000 shares@ US$6.2375.6% of flowCommon StockSEC:0001209191-18-047230:0Canonical exit: 12 Nov 2018 (T+90)
3 of 3 declarations
